- |||||||||| Enrollment closed: RSA RCT: ATTUNE (clinicaltrials.gov) - Mar 7, 2016
P=N/A, N=64, Active, not recruiting, Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Enrollment change: Autologous Stem Cells in Osteoarthritis (clinicaltrials.gov) - Mar 1, 2016
P1, N=61, Completed, Initiation date: Jan 2016 --> Jan 2017 Active, not recruiting --> Completed | N=30 --> 61
- |||||||||| AMG 108 / AstraZeneca
Trial completion: Treatment for Patients With Osteoarthritis (OA) (clinicaltrials.gov) - Feb 27, 2016 P2, N=160, Completed, Active, not recruiting --> Completed | N=30 --> 61 Active, not recruiting --> Completed
- |||||||||| Trial completion, Surgery: Evaluation of the TruMatch (clinicaltrials.gov) - Feb 17, 2016
P=N/A, N=64, Completed, Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Mar 2015 Recruiting --> Completed
- |||||||||| Trial completion, Trial primary completion date: SPLINTOA: Splinting to Treat Hand Osteoarthritis (clinicaltrials.gov) - Feb 17, 2016
P2, N=45, Completed, Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2011 --> Sep 2011
- |||||||||| Durolane (sodium hyaluronate) / Bioventus
Phase classification, Trial termination: Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee (clinicaltrials.gov) - Feb 12, 2016 P=N/A, N=290, Terminated, N=306 --> 446 Phase classification: P4 --> P=N/A | Suspended --> Terminated; post transfer of company ownership from Smith & Nephew to Bioventus LLC
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Use of a Novel Fibrin Sealant in Total Knee Arthroplasty (clinicaltrials.gov) - Feb 9, 2016
P2/3, N=73, Completed, Recruiting --> Active, not recruiting Recruiting --> Completed | N=140 --> 73 | Trial primary completion date: Dec 2015 --> Dec 2014
- |||||||||| hydroxychloroquine / Generic mfg., atorvastatin / Generic mfg.
Enrollment closed, Trial primary completion date: Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee (clinicaltrials.gov) - Feb 5, 2016 P2, N=21, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Feb 2016
- |||||||||| Enrollment closed, Trial primary completion date: Vitamin D and the Free Hormone Hypothesis (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=20, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Feb 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Feb 2015
- |||||||||| Trial completion, Trial primary completion date: Oxford Partial Knee Comparative Instrument Pilot Study (clinicaltrials.gov) - Feb 2, 2016
P=N/A, N=35, Completed, N=60 --> 33 | Recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Dec 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2015
- |||||||||| Trial primary completion date: Platelet Rich Plasma on Osteoarthritis of Knee (clinicaltrials.gov) - Feb 2, 2016
P=N/A, N=60, Recruiting, Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2015 Trial primary completion date: Feb 2016 --> May 2016
- |||||||||| Enrollment change: Rheumatic Diseases and Computer Use (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=359, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Nov 2017 N=1200 --> 359
- |||||||||| Trial primary completion date: 10003 PRO Current Products (clinicaltrials.gov) - Jan 20, 2016
P=N/A, N=840, Active, not recruiting, Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Dec 2016 --> Mar 2017
- |||||||||| Trial completion, Trial primary completion date: Cementless Alumina-Alumina Total Hip and Hybrid (clinicaltrials.gov) - Jan 20, 2016
P3, N=342, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Mar 2017 Active, not recruiting --> Completed | Trial primary completion date: Mar 2014 --> Jan 2015
- |||||||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial completion: Follow-Up Study of CARTISTEM (clinicaltrials.gov) - Jan 7, 2016 P3, N=103, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jul 2014 --> Apr 2015 Active, not recruiting --> Completed
- |||||||||| Maxigesic (acetaminophen/ibuprofen) / AFT Pharma, Hyloris Pharma, BioSyent, Hikma
Enrollment change, Trial withdrawal: Maxi-Analgesic Osteoarthritis (OA) Study (clinicaltrials.gov) - Jan 7, 2016 P3, N=0, Withdrawn, Active, not recruiting --> Completed N=400 --> 0 | Suspended --> Withdrawn
- |||||||||| Enrollment closed, Trial primary completion date: RAPID: Reducing Pain; Preventing Depression (clinicaltrials.gov) - Jan 7, 2016
P4, N=135, Active, not recruiting, N=400 --> 0 | Suspended --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Jun 2016
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date: Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study (clinicaltrials.gov) - Jan 5, 2016
P=N/A, N=31, Recruiting, Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Sep 2015 | Trial primary completion date: Feb 2016 --> Sep 2016
- |||||||||| Enrollment change, Trial primary completion date: Use of FlexHD as Post Trapeziectomy Spacer (clinicaltrials.gov) - Dec 29, 2015
P4, N=30, Recruiting, Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Sep 2015 | Trial primary completion date: Feb 2016 --> Sep 2016 N=60 --> 30 | Trial primary completion date: Dec 2015 --> Dec 2016
|